Medicalgorithmics S.A. (MDG.WA)
PLN 25.6
(-0.97%)
PLN 25.6
(-0.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 16.52 Million PLN | 2.91% |
| 2022 | 34.31 Million PLN | -70.81% |
| 2021 | 117.57 Million PLN | -14.55% |
| 2020 | 137.59 Million PLN | -16.72% |
| 2019 | 165.22 Million PLN | 0.25% |
| 2018 | 164.81 Million PLN | 5.99% |
| 2017 | 155.49 Million PLN | 98.98% |
| 2016 | 78.14 Million PLN | 239.47% |
| 2015 | 23.02 Million PLN | 168.57% |
| 2014 | 8.57 Million PLN | 71.62% |
| 2013 | 4.99 Million PLN | 62.74% |
| 2012 | 3.06 Million PLN | 32.04% |
| 2011 | 2.32 Million PLN | 84.42% |
| 2010 | 1.26 Million PLN | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 10.13 Million PLN | 10.25% |
| 2024 Q1 | 4.36 Million PLN | -54.11% |
| 2023 Q4 | 9.5 Million PLN | 6.59% |
| 2023 Q2 | 8.24 Million PLN | -4.55% |
| 2023 Q1 | 8.64 Million PLN | -11.42% |
| 2023 Q3 | 8.91 Million PLN | 8.12% |
| 2023 FY | 35.31 Million PLN | 2.91% |
| 2022 Q3 | 8.96 Million PLN | -42.41% |
| 2022 Q1 | 38.84 Million PLN | 49.31% |
| 2022 FY | 34.31 Million PLN | -70.81% |
| 2022 Q4 | 9.75 Million PLN | 8.87% |
| 2022 Q2 | 15.55 Million PLN | -59.94% |
| 2021 Q3 | 35.31 Million PLN | 56.41% |
| 2021 Q2 | 22.57 Million PLN | -33.56% |
| 2021 Q1 | 33.98 Million PLN | -1.67% |
| 2021 FY | 117.57 Million PLN | -14.55% |
| 2021 Q4 | 26.01 Million PLN | -26.34% |
| 2020 FY | 137.59 Million PLN | -16.72% |
| 2020 Q3 | 33.43 Million PLN | 19.17% |
| 2020 Q1 | 41.53 Million PLN | 2.98% |
| 2020 Q4 | 34.56 Million PLN | 3.36% |
| 2020 Q2 | 28.05 Million PLN | -32.45% |
| 2019 Q3 | 42.42 Million PLN | -0.23% |
| 2019 Q4 | 40.33 Million PLN | -4.92% |
| 2019 FY | 165.22 Million PLN | 0.25% |
| 2019 Q1 | 39.95 Million PLN | -7.28% |
| 2019 Q2 | 42.51 Million PLN | 6.43% |
| 2018 Q1 | 35.54 Million PLN | -8.54% |
| 2018 FY | 164.81 Million PLN | 5.99% |
| 2018 Q4 | 43.09 Million PLN | 0.55% |
| 2018 Q3 | 42.85 Million PLN | -1.31% |
| 2018 Q2 | 43.42 Million PLN | 22.16% |
| 2017 Q4 | 38.86 Million PLN | 11.91% |
| 2017 Q1 | 38.34 Million PLN | 941.3% |
| 2017 FY | 155.49 Million PLN | 98.98% |
| 2017 Q2 | 43.56 Million PLN | 13.59% |
| 2017 Q3 | 34.72 Million PLN | -20.28% |
| 2016 Q3 | 30.61 Million PLN | 24.49% |
| 2016 FY | 78.14 Million PLN | 239.47% |
| 2016 Q4 | 3.68 Million PLN | -87.97% |
| 2016 Q1 | 19.44 Million PLN | 223.66% |
| 2016 Q2 | 24.58 Million PLN | 26.45% |
| 2015 FY | 23.02 Million PLN | 168.57% |
| 2015 Q1 | 5.12 Million PLN | 210.87% |
| 2015 Q4 | 6 Million PLN | -17.81% |
| 2015 Q3 | 7.3 Million PLN | 59.69% |
| 2015 Q2 | 4.57 Million PLN | -10.71% |
| 2014 Q1 | 1.99 Million PLN | 47.74% |
| 2014 Q2 | 2.21 Million PLN | 10.79% |
| 2014 Q3 | 2.71 Million PLN | 22.46% |
| 2014 Q4 | 1.64 Million PLN | -39.17% |
| 2014 FY | 8.57 Million PLN | 71.62% |
| 2013 Q3 | 1.11 Million PLN | -20.38% |
| 2013 FY | 4.99 Million PLN | 62.74% |
| 2013 Q2 | 1.39 Million PLN | 22.55% |
| 2013 Q1 | 1.13 Million PLN | 32.74% |
| 2013 Q4 | 1.35 Million PLN | 21.82% |
| 2012 Q4 | 857.14 Thousand PLN | 1.45% |
| 2012 Q1 | 584.6 Thousand PLN | 0.0% |
| 2012 FY | 3.06 Million PLN | 32.04% |
| 2012 Q2 | 782.3 Thousand PLN | 33.82% |
| 2012 Q3 | 844.9 Thousand PLN | 8.0% |
| 2011 FY | 2.32 Million PLN | 84.42% |
| 2010 FY | 1.26 Million PLN | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Adiuvo Investments S.A. | 6.05 Million PLN | -172.832% |
| Genomtec S.A. | 7.93 Million PLN | -108.218% |
| Medinice S.A. | -5.7 Million PLN | 389.621% |
| Synektik Spólka Akcyjna | 83.04 Million PLN | 80.108% |